Kelly DV - Search Results

1

Evaluation of HIV drug interaction web sites.

Sheehan NL, Kelly DV, Tseng AL, van Heeswijk RP, Béïque LC, Hughes CA; Canadian HIV/AIDS Pharmacists Network. Sheehan NL, et al. Among authors: kelly dv. Ann Pharmacother. 2003 Nov;37(11):1577-86. doi: 10.1345/aph.1D039. Ann Pharmacother. 2003. PMID: 14565802

2

Extrapyramidal symptoms with ritonavir/indinavir plus risperidone.

Kelly DV, Béïque LC, Bowmer MI. Kelly DV, et al. Ann Pharmacother. 2002 May;36(5):827-30. doi: 10.1345/aph.1A335. Ann Pharmacother. 2002. PMID: 11978161

3

Abacavir hypersensitivity reaction: an update.

Hughes CA, Foisy MM, Dewhurst N, Higgins N, Robinson L, Kelly DV, Lechelt KE. Hughes CA, et al. Among authors: kelly dv. Ann Pharmacother. 2008 Mar;42(3):387-96. doi: 10.1345/aph.1K522. Epub 2008 Feb 26. Ann Pharmacother. 2008. PMID: 18303141 Review.

4

Comment: Abacavir hypersensitivity reaction: an update.

Hughes CA, Foisy MM, Dewhurst N, Higgins N, Robinson L, Kelly DV, Lechelt KE. Hughes CA, et al. Among authors: kelly dv. Ann Pharmacother. 2008 Oct;42(10):1519-20; author reply 1520-1. doi: 10.1345/aph.lK522b. Epub 2008 Sep 9. Ann Pharmacother. 2008. PMID: 18780810 No abstract available.

5

Expanding access to HIV testing through Canadian community pharmacies: findings from the APPROACH study.

Kelly DV, Kielly J, Hughes C, Gahagan J, Asghari S, Hancock S, Burt K, Smyczek P, Charlton C, Nguyen H. Kelly DV, et al. BMC Public Health. 2020 May 7;20(1):639. doi: 10.1186/s12889-020-08719-0. BMC Public Health. 2020. PMID: 32380978 Free PMC article.

6

Adaptation of POCT for pharmacies to reduce risk and optimize access to care in HIV, the APPROACH study protocol: examining acceptability and feasibility.

Kielly J, Kelly DV, Hughes C, Day K, Hancock S, Asghari S, Gahagan J, Marra C, Nguyen H. Kielly J, et al. Among authors: kelly dv. Pilot Feasibility Stud. 2018 Feb 27;4:59. doi: 10.1186/s40814-018-0252-1. eCollection 2018. Pilot Feasibility Stud. 2018. PMID: 30788134 Free PMC article.

7

Diagnosis and management of common chronic metabolic complications in HIV-infected patients.

Bader MS, Kelly DV. Bader MS, et al. Among authors: kelly dv. Postgrad Med. 2008 Nov;120(4):17-27. doi: 10.3810/pgm.2008.11.1930. Postgrad Med. 2008. PMID: 19020362 Review.

8

Target users' acceptance of a pharmacist-led prescribing service for pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV).

MacDonald CB, Murphy AL, Isenor JE, Ramsey TD, Furlotte K, Smith AJ, Bishop A, Kelly DV, Woodill L, Booker C, Wilby KJ. MacDonald CB, et al. Among authors: kelly dv. Can Pharm J (Ott). 2023 Jun 12;156(4):194-203. doi: 10.1177/17151635231177027. eCollection 2023 Jul-Aug. Can Pharm J (Ott). 2023. PMID: 37435507 Free PMC article.

9

Barriers and enablers to testing for hepatitis C virus infection in people who inject drugs - a scoping review of the qualitative evidence.

Balsom CR, Farrell A, Kelly DV. Balsom CR, et al. Among authors: kelly dv. BMC Public Health. 2023 Jun 1;23(1):1038. doi: 10.1186/s12889-023-16017-8. BMC Public Health. 2023. PMID: 37259073 Free PMC article. Review.

10

Community pharmacists' acceptance of prescribing pre-exposure prophylaxis (PrEP) for human immunodeficiency virus (HIV).

Booker C, Murphy AL, Isenor JE, Ramsey TD, Smith AJ, Bishop A, Kelly DV, Woodill L, Richard G, John Wilby K. Booker C, et al. Among authors: kelly dv. Can Pharm J (Ott). 2023 Feb 28;156(3):137-149. doi: 10.1177/17151635231152218. eCollection 2023 May-Jun. Can Pharm J (Ott). 2023. PMID: 37201164 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

20 results

Search Page